The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia The primary purpose of the study is to describe by a prospective observational study the serious adverse events occurring in patients treated off-label by rituximab for Immune Thrombocytop...

• Pays France
• Organes Aucun
• Spécialités Aucune